Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

Business Wire

Published

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight Software delivers ready-made infrastructure to realize the full potential of whole-genome sequencing for rare genetic diseases. This new offering enables sample-to-report analysis for genetic disease testing, giving customers an integrated solution that focuses on one

Full Article